MedTrace Logo

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

NCT01037829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4529

Last updated 2011-09-29

No results posted yet for this study

Summary

The primary objective of this observational, comparative safety study is to evaluate the safety of the Novartis Pandemic Influenza A (H1N1) vaccine in pregnant women and their off spring, followed for up to 3 months of age as compared to pregnant women who have not received the Novartis Pandemic Influenza A (H1N1) vaccine. This study will be conducted at investigative sites within the Netherlands, Italy, and Argentina.

Conditions

Interventions

OTHER

Non-intervention observational study

Non-intervention observational study

Sponsors & Collaborators

  • Novartis Vaccines

    lead INDUSTRY

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Argentina
  • Italy
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01037829 on ClinicalTrials.gov